Clinical Trials Logo
  1. Home
  2. Wound Healing Disorder
  3. NCT03720119

Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®

Wound Healing Disorder Clinical Trial

Official title:
Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®

Clinical Trial Summary

Acute pain may occur due to trauma, surgery, infection, disruption of blood circulation or when there is tissue injury. It can be managed using analgesics and conduction anaesthesia, which may be preferable because of superior pain control and fewer side effects. Lidocaine hydrochloride is used topically to relieve itching, burning and pain from skin inflammation. This multicentric observational study is aimed to evaluate the relief gained with lidocaine hydrochloride (ORTODERMINA®) on wound pain in patients with painful wounds and to collect safety information on this treatment.

Clinical Trial Description

Acute pain can be managed using analgesics and conduction anaesthesia which may be preferable because of superior pain control and fewer side effects. In this contest, lidocaine hydrochloride (ORTODERMINA®) plays an important role in pain management during wound healing. The properties of ORTODERMINA® and its ability to maintain an adequate level of active drug over the lesion allow a persistent anaesthetic effect. ORTODERMINA® is a drug for topical application in the form of cream, with a high safety profile. However, although the incidence of adverse effects with Lidocaine Ointment 5% is quite low, caution should be exercised, particularly when employing large amounts, since the incidence of adverse effects is directly proportional to the total dose of local anaesthetic agent administered. This multicentric observational study is aimed to evaluate the relief gained with ORTODERMINA® on wound pain in patients with painful wounds and to collect safety information on this treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03720119
Study type Observational
Source SOFAR S.p.A.
Contact
Status Completed
Phase
Start date January 27, 2015
Completion date March 5, 2018
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05608187 - Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers Phase 2
Completed NCT05101473 - Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study N/A
Completed NCT05098314 - Impact of Personalized Interventions to Raise Teleconsultation Awareness in EHPAD
Recruiting NCT03314350 - Prevalence of Wound Healing Disturbances in Geriatric Inpatients (WONDER Study)
Completed NCT04446767 - Photobiomodulation With Polarized Light as Adjunctive Treatment in Diabetic Foot Ulcer N/A
Completed NCT05509673 - Lipofilling for Healing of Chronic Wounds N/A
Not yet recruiting NCT06420323 - NovoX®Cup as Primary Dressing After Breast Reduction
Recruiting NCT06284538 - Study to Evaluate the Effectiveness of a Medical Device Based on Hyaluronic Acid in Wounds N/A
Completed NCT01528033 - Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments N/A
Completed NCT06371430 - Bone Bioactive Liquid Efficiency in Improving Dental Implant Osteointegration Oral Soft Tissue Hellingand Oral Surgery N/A